Technical Analysis for PARNF - Parnell Pharmaceuticals Holdings Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | 100.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Get this analysis on your stocks daily!
Parnell Pharmaceuticals Holdings Ltd. Description
Parnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Industry Pharmaceutical Products Pharmacy Pharmacology Arthritis Nutraceutical Software Platform Hormone Osteoarthritis Companion Nutraceutical Product Manufacturing Operations Dax Health Solutions Software Platforms Steroid Veterinary Pharmaceutical Treatment Of Osteoarthritis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 0.89 |
52 Week Low | 0.0001 |
Average Volume | 7,188 |
200-Day Moving Average | 0.2525 |
50-Day Moving Average | 0.1360 |
20-Day Moving Average | 0.0283 |
10-Day Moving Average | 0.0006 |
Average True Range | 0.0142 |
RSI | 32.89 |
ADX | 12.67 |
+DI | 37.8811 |
-DI | 43.4283 |
Chandelier Exit (Long, 3 ATRs) | 0.1573 |
Chandelier Exit (Short, 3 ATRs) | 0.0427 |
Upper Bollinger Bands | 0.1141 |
Lower Bollinger Band | -0.0575 |
Percent B (%b) | 0.35 |
BandWidth | 606.3604 |
MACD Line | -0.0409 |
MACD Signal Line | -0.0465 |
MACD Histogram | 0.0056 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.0020 | ||||
Resistance 3 (R3) | 0.0020 | 0.0020 | 0.0020 | ||
Resistance 2 (R2) | 0.0020 | 0.0020 | 0.0020 | 0.0020 | |
Resistance 1 (R1) | 0.0020 | 0.0020 | 0.0020 | 0.0020 | 0.0020 |
Pivot Point | 0.0020 | 0.0020 | 0.0020 | 0.0020 | 0.0020 |
Support 1 (S1) | 0.0020 | 0.0020 | 0.0020 | 0.0020 | 0.0020 |
Support 2 (S2) | 0.0020 | 0.0020 | 0.0020 | 0.0020 | |
Support 3 (S3) | 0.0020 | 0.0020 | 0.0020 | ||
Support 4 (S4) | 0.0020 |